The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection

類似資料

• The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection
  著者:: Yumin Zhang, 等
  出版事項: (2025-12-01)
• The impact of antiviral therapy on hepatocellular carcinoma epidemiology
  著者:: Massimo Colombo, 等
  出版事項: (2018-01-01)
• Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses
  著者:: Weiyong Liu, 等
  出版事項: (2023-11-01)
• An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
  著者:: Yinzhong Shen, 等
  出版事項: (2022-12-01)
• Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report
  著者:: Jiaying Zhang, 等
  出版事項: (2025-01-01)